Clinical trial
Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of…
NCT00409656 · University Hospital Freiburg, Other · Completed
Key facts
| NCT number | NCT00409656 |
|---|---|
| Title | Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients |
| Official title | Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients |
| Lead sponsor | University Hospital Freiburg, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Corneal Transplantation |
| Intervention type | Drug |
| Interventions | Basiliximab |
| Start date | Dec 1, 2003 |
| Completion | Dec 1, 2005 |
| First posted | Dec 11, 2006 |
| Last update posted | Dec 13, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: